For The First Time In Two Quarters, CV Sciences, Inc (OTCMKTS: CVSI) Announces a 6% Increase in Revenue in its Q2 2021 Financial Results
Cultivating and commercializing CBD-based novel therapeutics is seemingly the primary mission for every supplier and manufacturer of hemp cannabidiol (CBD)…